Clinical Trials

NCT02390752 | RECRUITING | PHASE1
54 participants

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2015-04-29
Completion:
2026-12-31
Conditions
  • Neurofibroma, Plexiform
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Leukemia, Promyelocytic, Acute
  • Sarcoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page